Avexa Limited, a biotechnology company, is engaged in the research and development, and commercialization of anti-infective pharmaceutical programs and projects for the treatment of human immunodeficiency virus (HIV). The company provides apricitabine, a nucleoside reverse transcriptase inhibitor for the treatment of HIV infection. It also offers Integrase, an anti-retroviral drug; and antibiotics. In addition, the company owns the North Pratt coal mine located in North Pratt, Alabama. Avexa Limited was founded in 2004 and is based in Hawthorn East, Australia.
(AVX:Australian Stock Exchange Ltd)
61-63 Camberwell Road
Hawthorn East, VIC 3123
Phone: 61 3 8888 1040
|Bristol-Myers Squibb Co||$64.60 USD||-4.55|
|Gilead Sciences Inc||$112.27 USD||-0.58|
|Merck & Co Inc||$60.89 USD||+1.19|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact AVEXA LTD, please visit www.avexa.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.